Phylo has collaborated with Chugai Pharmaceutical to implement the Biomni Lab platform within the latter’s drug discovery operations.The post Phylo...
Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing...
Ascletis Pharma has begun a global Phase III clinical programme for its once-daily oral small molecule GLP-1 receptor agonist, ASC30,...
CapVest Partners-backed Curium has agreed to acquire rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly...
Moleculin Biotech has reported preliminary blinded data from Part A of its ongoing pivotal Phase II/III MIRACLE trial assessing AnnAraC...
CereVasc has opened a new manufacturing and research facility in Wilmington, Massachusetts, as the company prepares for potential commercialisation of...
Ratio Therapeutics, a US-based developer of radiopharmaceuticals for cancer treatment, has closed a $70m Series C financing round.The post Ratio...
Median Technologies has partnered with Olea Medical to support the commercialisation of its eyonis LCS software in the US and...
Evommune has initiated a Phase IIb clinical trial of EVO756 for the prophylactic migraine treatment with the dosing of the...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.